The present invention relates to compounds of formula (I)
##STR1##
wherein wherein R1, R2, R3, R4,
R5, R6 and n are as described herein. The compounds of the
present invention can be used as medicaments for the treatment and/or prevention
of diseases which are modulated by PPAR and/or PPAR agonists. Examples
of such diseases are diabetes, particularly non-insulin dependent diabetes mellitus,
elevated blood pressure, increased lipid and cholesterol levels, atherosclerotic
diseases, metabolic syndrome, endothelial dysfunction, procoagulant state, dyslipidemia,
polycystic ovary syndrome, inflammatory diseases (such as e.g. crown disease, inflammatory
bowel disease, collitis, pancreatitis, cholestasis/fibrosis of the liver, and diseases
that have an inflammatory component such as e.g. Alzheimer's disease or impaired/improvable
cognitive function) and proliferative diseases.